Later, in 2017, a novel germline EPHB4 mutation was detected in RASA-1-negative CM-AVMs, mimicking RASA1-related CM-AVM1 and HHT [8]. This evidence concerns the gene EPHB4 and hereditary hemorrhagic telangiectasia.